BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 32508294)

  • 1. DNA damage checkpoint kinases in cancer.
    Smith HL; Southgate H; Tweddle DA; Curtin NJ
    Expert Rev Mol Med; 2020 Jun; 22():e2. PubMed ID: 32508294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chk1 and Wee1 control genotoxic-stress induced G2-M arrest in melanoma cells.
    Vera J; Raatz Y; Wolkenhauer O; Kottek T; Bhattacharya A; Simon JC; Kunz M
    Cell Signal; 2015 May; 27(5):951-60. PubMed ID: 25683911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
    Lossaint G; Besnard E; Fisher D; Piette J; Dulić V
    Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-nitroso-N-ethylurea activates DNA damage surveillance pathways and induces transformation in mammalian cells.
    Bodakuntla S; Libi AV; Sural S; Trivedi P; Lahiri M
    BMC Cancer; 2014 Apr; 14():287. PubMed ID: 24758542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ataxia telangiectasia mutated (ATM) and ATM and Rad3-related protein exhibit selective target specificities in response to different forms of DNA damage.
    Helt CE; Cliby WA; Keng PC; Bambara RA; O'Reilly MA
    J Biol Chem; 2005 Jan; 280(2):1186-92. PubMed ID: 15533933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer.
    Smith J; Tho LM; Xu N; Gillespie DA
    Adv Cancer Res; 2010; 108():73-112. PubMed ID: 21034966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ataxia-telangiectasia-mutated (ATM) and NBS1-dependent phosphorylation of Chk1 on Ser-317 in response to ionizing radiation.
    Gatei M; Sloper K; Sorensen C; Syljuäsen R; Falck J; Hobson K; Savage K; Lukas J; Zhou BB; Bartek J; Khanna KK
    J Biol Chem; 2003 Apr; 278(17):14806-11. PubMed ID: 12588868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Key Proteins of Replication Stress Response and Cell Cycle Control as Cancer Therapy Targets.
    Khamidullina AI; Abramenko YE; Bruter AV; Tatarskiy VV
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHK1 and CHK2 are differentially involved in mismatch repair-mediated 6-thioguanine-induced cell cycle checkpoint responses.
    Yan T; Desai AB; Jacobberger JW; Sramkoski RM; Loh T; Kinsella TJ
    Mol Cancer Ther; 2004 Sep; 3(9):1147-57. PubMed ID: 15367709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting DNA checkpoint kinases in cancer therapy.
    Zhou BB; Anderson HJ; Roberge M
    Cancer Biol Ther; 2003; 2(4 Suppl 1):S16-22. PubMed ID: 14508077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological inactivation of CHK1 and WEE1 induces mitotic catastrophe in nasopharyngeal carcinoma cells.
    Mak JP; Man WY; Chow JP; Ma HT; Poon RY
    Oncotarget; 2015 Aug; 6(25):21074-84. PubMed ID: 26025928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol analogue (E)-8-acetoxy-2-[2-(3,4-diacetoxyphenyl)ethenyl]-quinazoline induces G₂/M cell cycle arrest through the activation of ATM/ATR in human cervical carcinoma HeLa cells.
    Kim JY; Choi HE; Lee HH; Shin JS; Shin DH; Choi JH; Lee YS; Lee KT
    Oncol Rep; 2015 May; 33(5):2639-47. PubMed ID: 25812484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imatinib inhibits inactivation of the ATM/ATR signaling pathway and recovery from adriamycin/doxorubicin-induced DNA damage checkpoint arrest.
    Morii M; Fukumoto Y; Kubota S; Yamaguchi N; Nakayama Y; Yamaguchi N
    Cell Biol Int; 2015 Aug; 39(8):923-32. PubMed ID: 25790472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional interplay between ATM/ATR-mediated DNA damage response and DNA repair pathways in oxidative stress.
    Yan S; Sorrell M; Berman Z
    Cell Mol Life Sci; 2014 Oct; 71(20):3951-67. PubMed ID: 24947324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitotic DNA damage response: Polo-like kinase-1 is dephosphorylated through ATM-Chk1 pathway.
    Lee HJ; Hwang HI; Jang YJ
    Cell Cycle; 2010 Jun; 9(12):2389-98. PubMed ID: 20581453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis.
    Pabla N; Huang S; Mi QS; Daniel R; Dong Z
    J Biol Chem; 2008 Mar; 283(10):6572-83. PubMed ID: 18162465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PNAS-4, an Early DNA Damage Response Gene, Induces S Phase Arrest and Apoptosis by Activating Checkpoint Kinases in Lung Cancer Cells.
    Yuan Z; Guo W; Yang J; Li L; Wang M; Lei Y; Wan Y; Zhao X; Luo N; Cheng P; Liu X; Nie C; Peng Y; Tong A; Wei Y
    J Biol Chem; 2015 Jun; 290(24):14927-44. PubMed ID: 25918161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Src family kinases promote silencing of ATR-Chk1 signaling in termination of DNA damage checkpoint.
    Fukumoto Y; Morii M; Miura T; Kubota S; Ishibashi K; Honda T; Okamoto A; Yamaguchi N; Iwama A; Nakayama Y; Yamaguchi N
    J Biol Chem; 2014 May; 289(18):12313-29. PubMed ID: 24634213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the ATR-CHK1 Pathway in Ewing Sarcoma Cells Causes DNA Damage and Apoptosis via the CDK2-Mediated Degradation of RRM2.
    Koppenhafer SL; Goss KL; Terry WW; Gordon DJ
    Mol Cancer Res; 2020 Jan; 18(1):91-104. PubMed ID: 31649026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoblasts survive the arsenic trioxide treatment by activation of ATM-mediated pathway.
    Hu YC; Hsieh BS; Cheng HL; Huang LW; Huang TC; Huang IY; Chang KL
    Biochem Pharmacol; 2013 Apr; 85(7):1018-26. PubMed ID: 23337567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.